Chemokine interferon inducible protein 10
EmergingCXCL10, alongside CXCL9, supports HLH/MAS diagnosis as part of the interferon-gamma-driven inflammatory marker panel.
CXCL10 is released when interferon-gamma signaling is very active, which happens in a dangerous immune overactivation condition called HLH. It's tested alongside several related markers to help confirm this diagnosis in critically ill patients.
CXCL10 (IP-10) is an interferon-gamma-induced chemokine that recruits activated T-cells to sites of inflammation, with particular relevance to hyperinflammatory syndromes.
Alongside CXCL9 (discussed separately in this set), CXCL10 is part of the interferon-gamma-driven inflammatory cascade increasingly used to support diagnosis and severity assessment of hemophagocytic lymphohistiocytosis (HLH) and macrophage activation syndrome (MAS).
Measured via serum immunoassay, typically as part of a broader cytokine panel alongside ferritin, soluble CD25, IL-18, and CXCL9 when HLH/MAS is suspected in a critically ill patient.
Elevated CXCL10, especially alongside the other interferon-driven markers in this panel, supports more confident HLH/MAS diagnosis and can help guide the decision to escalate to HLH-directed immunosuppressive therapy.
Part of an actively evolving, more sophisticated cytokine panel approach to diagnosing hyperinflammatory syndromes.
- General hematology/immunology reference literature on interferon-gamma-induced chemokines (CXCL9, CXCL10) in HLH/MAS diagnosis.